NEW YORK (Reuters Health) – Certain disease-modifying antirheumatic drugs (DMARDs) may lower the risk of diabetes in patients with rheumatoid arthritis (RA) or psoriasis, according to an observational…
NEW YORK (Reuters Health) – While angiotensin receptor blockers (ARBs) as a class do not appear to be associated with an increased malignancy risk in patients with diabetes,…
NEW YORK (Reuters Health) – When acute appendicitis is suspected, preoperative assessment by multidetector computed tomography (MDCT) has very high positive and negative predictive values, according to the…
NEW YORK (Reuters Health) – Implantable cardioverter-defibrillators (ICDs) may not improve survival for patients in their 80s and 90s, according to a report in the June 2nd online…
NEW YORK (Reuters Health) – The average of five or six blood pressure measurements are needed in order to classify patients with reasonable certainty as having blood pressure…
NEW YORK (Reuters Health) – Men with benign prostatic hyperplasia experience a similar reduction in urinary symptoms whether they’re treated with dutasteride or finasteride, according to the results…
NEW YORK (Reuters Health) – In pregnancy, antiepileptic drug (AED) polytherapy that includes valproate poses a higher risk of fetal malformations than therapy without this drug, according to…
NEW YORK (Reuters Health) – For patients with severe uncontrolled asthma, adding inhaled tiotropium to standard treatment improves lung function significantly, according to a study published June 3rd…
NEW YORK (Reuters Health) – The dilemma of when to start antiretroviral therapy (ART) in patients presenting with tuberculous meningitis associated with HIV infection has been answered by…
NEW YORK (Reuters Health) – A comparison trial conducted in Taiwan indicates that silodosin improves lower urinary tract symptoms associated with benign prostatic hyperplasia at least as well…